search
Back to results

Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection

Primary Purpose

HIV, Pregnancy

Status
Completed
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
PartnerPlus Intervention
Usual Care
Sponsored by
University of Miami
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV focused on measuring HIV, Pregnancy, Prevention, Couples

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • pregnant women age 18 and older who have received HCT (HIC Counseling & Testing) at the antenatal clinic (ANC),
  • willing to attend PartnerPlus or prevention of mother to child transmission (PMTCT) visits with their male partners,
  • male partners must also be available to participate and
  • both partners must be willing to participate in the study.
  • All participants will be current adult residents of Mpumalanga Province and agree to be attend four group sessions, 2 psychosocial assessments and 1 three day post-delivery assessment (maternal and infant blood sample).

Exclusion Criteria:

  • Single mothers not being tested for HIV at the ANC

Sites / Locations

  • Human Sciences Research Council

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Experimental

Arm Label

Usual Care

PartnerPlus intervention

Arm Description

Participation in 4 time matched sessions on health education topics

Four group counseling sessions focused on prevention of mother to child transmission (PMTCT) sexual risk reduction & adherence.

Outcomes

Primary Outcome Measures

Change in number of ANC visits by mother and father from baseline to one month post intervention to 32 weeks to 3 days post partum

Secondary Outcome Measures

Change in Mother, father, infant HIV VCT from baseline to one month to 3 days post partum
Mother and infant ARV prophylaxis
Change in Maternal PMTCT ARV uptake from baseline to 32 weeks to 3 days post partum
Infant PCR
Change in rate of condom use from baseline to one month to 3 days post partum

Full Information

First Posted
September 26, 2011
Last Updated
January 20, 2014
Sponsor
University of Miami
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
search

1. Study Identification

Unique Protocol Identification Number
NCT01448512
Brief Title
Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection
Official Title
University of Miami Developmental Center for AIDs Research Promoting Male Involvement to Improve PMTCT Uptake and Reduce Antenatal Infection
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
September 2010 (undefined)
Primary Completion Date
August 2012 (Actual)
Study Completion Date
August 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Miami
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will evaluate the impact of combining two evidence-based interventions: a couples risk reduction intervention with an evidence based medication adherence intervention designed to enhance male participation in combination with improving medication and prevention of mother to child transmission (PMTCT) adherence in antenatal clinics (ANCs). Clinics will be randomly assigned to experimental and control conditions and effectiveness of the combined intervention to enhance PMTCT as well as reduce antenatal seroconversion by both individuals and clinics will be examined. It is hypothesized that community clinics implementing PartnerPlus will have more effective PMTCT program adherence, as measured by total participant 1) maternal and paternal ANC and PartnerPlus visits, 2) maternal and paternal human immunodeficiency virus (HIV) Counseling & Testing (HCT) uptake, 3) maternal and infant antiretroviral (ARV) prophylaxis uptake, 4) maternal highly active antiretroviral therapy (HAART) uptake, 5) infant polymerase chain reaction (PCR) for HIV, and 5) maternal and infant HIV serostatus and that community clinics implementing PartnerPlus will have reduced sexual risk behavior, as measured by participant sexual barrier use.
Detailed Description
This study is a group-randomized controlled trial using a 2 x 6 comparison (Clinic, Experimental, Control x Time, Baseline, Post-Intervention, Pre-delivery 32 weeks, Pre-delivery day, Delivery, Post Partum). Twelve community health centers (CHCs) in communities within the Gert Sibande and Nkangala Districts in Mpumalanga, South Africa (SA) will be randomly assigned to condition in a 1:1 ratio. Six usual care condition clinics will provide the standard of care, PMTCT; six experimental condition clinics will offer PartnerPlus to mothers completing HIV testing, regardless of serostatus, who are willing to enroll with their male partners and participate in the integrated PartnerPlus intervention. This study will recruit 240 couples (n = 480 individuals); community clinics will recruit 2 cohort per clinic over 3 months (10 couples per cohort, n = 40, 120 individuals per condition).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Pregnancy
Keywords
HIV, Pregnancy, Prevention, Couples

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
478 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
Other
Arm Description
Participation in 4 time matched sessions on health education topics
Arm Title
PartnerPlus intervention
Arm Type
Experimental
Arm Description
Four group counseling sessions focused on prevention of mother to child transmission (PMTCT) sexual risk reduction & adherence.
Intervention Type
Behavioral
Intervention Name(s)
PartnerPlus Intervention
Other Intervention Name(s)
Cognitive behavioral risk reduction intervention
Intervention Description
The intervention employs a closed, structured, group intervention limited to 10 participants (women or men). Four weekly, 11/2-2 hour sessions are led by a trained gender-congruent counselor and a peer facilitator and emphasize group participation, cognitive-behavioral skill building, sexual negotiation and experimentation with products.
Intervention Type
Other
Intervention Name(s)
Usual Care
Other Intervention Name(s)
Standard of Care
Intervention Description
4 time matched sessions focused on health education
Primary Outcome Measure Information:
Title
Change in number of ANC visits by mother and father from baseline to one month post intervention to 32 weeks to 3 days post partum
Time Frame
Baseline, one month, 32 weeks, 3 days post partum
Secondary Outcome Measure Information:
Title
Change in Mother, father, infant HIV VCT from baseline to one month to 3 days post partum
Time Frame
Baseline, one month, 3 days post partum
Title
Mother and infant ARV prophylaxis
Time Frame
3 days post partum
Title
Change in Maternal PMTCT ARV uptake from baseline to 32 weeks to 3 days post partum
Time Frame
Baseline, 32 weeks, 3 days post partum
Title
Infant PCR
Time Frame
6 weeks
Title
Change in rate of condom use from baseline to one month to 3 days post partum
Time Frame
Baseline, one month, 3 days post partum

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: pregnant women age 18 and older who have received HCT (HIC Counseling & Testing) at the antenatal clinic (ANC), willing to attend PartnerPlus or prevention of mother to child transmission (PMTCT) visits with their male partners, male partners must also be available to participate and both partners must be willing to participate in the study. All participants will be current adult residents of Mpumalanga Province and agree to be attend four group sessions, 2 psychosocial assessments and 1 three day post-delivery assessment (maternal and infant blood sample). Exclusion Criteria: Single mothers not being tested for HIV at the ANC
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karl Peltzer, PhD
Organizational Affiliation
Human Sciences Research Council
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Deborah Jones, PhD
Organizational Affiliation
University of Miami
Official's Role
Principal Investigator
Facility Information:
Facility Name
Human Sciences Research Council
City
Pretoria
State/Province
Gauteng
Country
South Africa

12. IPD Sharing Statement

Learn more about this trial

Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection

We'll reach out to this number within 24 hrs